Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 22 hours 19 min ago
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024 5/31/2024
BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM
BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM 5/30/2024
Immunovant Shifts Focus to Other FcRn Inhibitor, Gives Rival Vyvgart Breathing Room
Immunovant Shifts Focus to Other FcRn Inhibitor, Gives Rival Vyvgart Breathing Room 5/30/2024
Tris Pharma Gets FDA Approval for Non-Stimulant ADHD Medication
Tris Pharma Gets FDA Approval for Non-Stimulant ADHD Medication 5/30/2024
Biohaven’s Phase I Data for Lead Protein Degrader Disappoints Investors
Biohaven’s Phase I Data for Lead Protein Degrader Disappoints Investors 5/30/2024
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion 5/30/2024
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa 5/30/2024
Early-Stage Biotechs Now Tying CEO Pay Packages to Capital Raises
Early-Stage Biotechs Now Tying CEO Pay Packages to Capital Raises 5/30/2024
Moving Up: 5 Tips for Transitioning From Co-Worker to Manager
Moving Up: 5 Tips for Transitioning From Co-Worker to Manager 5/30/2024
Merck’s Potential $3B EyeBio Acquisition Puts Drugmaker Back in Ophthalmology
Merck’s Potential $3B EyeBio Acquisition Puts Drugmaker Back in Ophthalmology 5/29/2024
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris 5/29/2024
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters 5/29/2024
Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study
Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study 5/29/2024
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO 5/29/2024
Who Will the Next “Big Pharma” Players Be?
Who Will the Next “Big Pharma” Players Be? 5/29/2024
How Realistic is AstraZeneca’s $80B Revenue Target by 2030?
How Realistic is AstraZeneca’s $80B Revenue Target by 2030? 5/29/2024
J&J Scores Phase III Victory in Major Depressive Disorder
J&J Scores Phase III Victory in Major Depressive Disorder 5/29/2024
Biopharma IPOs From the First Half of 2024
Biopharma IPOs From the First Half of 2024 5/29/2024
Can AI Help Biopharma Companies Go Green?
Can AI Help Biopharma Companies Go Green? 5/29/2024
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor 5/29/2024
World Pharma News
- Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
- Study shows ancient viruses fuel modern-day cancers
- Darolutamide meets primary endpoint in Phase III ARANOTE trial
- Pfizer advances development of once-daily formulation of oral GLP-1 receptor agonist danuglipron
- New AI approach optimizes antibody drugs